Answer
The safety and efficacy of sotorasib (Lumykras) in children and adolescents under 18 years have not been established, and no data are available.
Sources for this answer
- LUMYKRAS 240 mg film-coated tabletsAmgen Ltd · emc · SmPC §4.2 Posology and method of administration · Version 3Document updated
Sources checked